ECU
BMY icon

Eisler Capital (US)’s Bristol-Myers Squibb BMY Stock Holding History

Eisler Capital (US)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$331K Sell
6,390
-11,620
-65% -$545K 0.01% 445
2024
Q2 		$748K Buy
+18,010
New +$806K 0.01% 532

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Eisler Capital (US)'s BMY Position: Q3 2024 in Review

Eisler Capital (US) reduced its Bristol-Myers Squibb (BMY) stake by 65% in Q3 2024, selling an estimated $545K and leaving 6,390 shares worth $331K. The position accounts for 0.01% of the portfolio, ranked #445.

Eisler Capital (US) first reported a position in BMY in Q2 2024 and has held it in 2 quarters since. The position peaked at $748K in Q2 2024. 2,261 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Eisler Capital (US) held 6,390 shares of Bristol-Myers Squibb worth $331K as of Q3 2024.
  • Eisler Capital (US) sold 11,620 Bristol-Myers Squibb shares in Q3 2024, an estimated $545K.
  • Bristol-Myers Squibb made up 0.01% of Eisler Capital (US)'s portfolio in Q3 2024, its #445 holding.
  • Eisler Capital (US) first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 2 quarters since.
  • Eisler Capital (US)'s Bristol-Myers Squibb position peaked at $748K in Q2 2024.
  • 2,261 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Eisler Capital (US)'s 13F filing for Q3 2024, filed 14 Nov 2024.